Health Genesis Corporation
Davie, FL, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Health Genesis Corporation is a dietary supplement manufacturer in Davie, FL, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, gummies, powders, softgels and tablets.
- Phone
- 800-595-6593
- Facilities listed
- 2
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Products on its USDA Organic certificate
Product types among the organic items that Health Genesis Corporation’s certified operation lists in the USDA Organic Integrity Database.
Probiotics1 item
- D-Mannonse + Cranberry + Probiotics
As written in the USDA Organic Integrity Database.
Probiotic manufacturers →Herbal & botanical8 items
- Holy Basil Capsules
- Milk Thistle + Piperine
- Moringa Capsules
- Red Korean Panax Ginseng Capsules
- Sea Moss + Bladderwrack & Burdock Capsules
- Stinging Nettle Capsules
- Turmeric Capsules
- Turmeric Fenugreek Complex Tablets (non-retail)
As written in the USDA Organic Integrity Database.
Herbal supplement manufacturers →Vitamins & minerals1 item
- Vitamin D-3 + K-2 Complex Capsules
As written in the USDA Organic Integrity Database.
Vitamin manufacturers →Mushrooms3 items
- Chaga Mushroom Capsule
- Lion's Mane Capsules
- Mushroom Complex Capsules
As written in the USDA Organic Integrity Database.
Mushroom supplement manufacturers →
USDA Organic Integrity Database, operation 5561006087, checked .
These are organic items only: the certificate says nothing about the company’s non-organic products. A listed item is the certifier’s record of what the operation is certified to handle organically, not a test of the product. About USDA Organic item lists
Certified facilities
Manufacturing (2)
4131 SW 47th Ave., Suite 1404, Davie, FL 33314, United States
- Dry Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
4011 SW 47th Avenue, Suite 1101, Davie, FL 33314, United States
- Encapsulation
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Warehousing
How Health Genesis Corporation compares
Among the 769 manufacturers we list, as of our last check.
- One of 22 gummy manufacturers we list in Florida, and 116 in the United States. All gummy manufacturers in the USA · All in Florida
- One of 43 capsule manufacturers we list in Florida, and 325 in the United States. All capsule manufacturers in the USA · All in Florida
- One of 33 tablet manufacturers we list in Florida, and 228 in the United States. All tablet manufacturers in the USA · All in Florida
- On 2 of the registries we check: NSF/ANSI 455-2 and USDA Organic. 165 of the 769 manufacturers we list are on 2 or more.
- Has 2 listed manufacturing or packaging facilities; 71% of the manufacturers we list have fewer.
FDA recall records
No food or dietary supplement recall found under the name Health Genesis Corporation in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 7 food or dietary supplement inspections at facilities matching Health Genesis Corporation, from 2013 to 2025, as of . 2 found no objectionable conditions, 3 found conditions the firm was left to correct, and 2 led FDA to recommend official action.
No action indicated · No objectionable conditions found
Inspected
Davie, Florida
FEI 3002767376
No action indicated · No objectionable conditions found
Inspected
Davie, Florida
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
9 citations posted:
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
- Instruments - calibration (21 CFR 111.27(b))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Quality control - reject; specification not met (21 CFR 111.113(b)(2))
See all 9 citations
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
Instruments - calibration (21 CFR 111.27(b))
You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement before the first use to ensure the accuracy and precision of the instruments or controls.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a component, dietary supplement, package and label when an established specification was not met.
Rejected dietary supplements - identify, hold, control (21 CFR 111.370)
You did not clearly identify, hold and control under a quarantine system for appropriate disposition a dietary supplement that was rejected and unsuitable for use in manufacturing, packaging, or labeling operations.
Obsolete labels, packaging - dispose (21 CFR 111.415(h))
You did not suitably dispose of labels and packaging for dietary supplements that are obsolete or incorrect to ensure that they are not used in any future packaging and label operations.
Written procedures - holding (21 CFR 111.453)
You did not establish and follow written procedures for holding and distributing operations.
Record - product complaint; good manufacturing practice (21 CFR 111.570(b)(2))
You did not make and keep a written record of every product complaint that was related to good manufacturing practice.
Raw materials - Allergen identification (21 CFR 117.80(b)(8))
You did not identify and hold raw materials and other ingredients that are food allergens, and rework that contains food allergens, in a manner that protects against allergen cross-contact.
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
6 citations posted:
- Instruments - calibration (21 CFR 111.27(b))
- Quality control - reject; specification not met (21 CFR 111.113(b)(2))
- Product received - identify (21 CFR 111.165(d)(1))
- Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))
See all 6 citations
Instruments - calibration (21 CFR 111.27(b))
You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement at the frequency specified in writing by the manufacturer or at routine intervals or as necessary to ensure the accuracy and precision of the instruments or controls.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a component when an established specification was not met.
Product received - identify (21 CFR 111.165(d)(1))
You did not identify each unique lot within each unique shipment of received product in a manner that allows you to trace the lot to the status of the received product.
Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))
Your batch production records did not include documentation that quality control personnel reviewed required monitoring operations.
Obsolete labels, packaging - dispose (21 CFR 111.415(h))
You did not suitably dispose of labels and packaging for dietary supplements that are obsolete or incorrect to ensure that they are not used in any future packaging and label operations.
Written procedures - holding (21 CFR 111.453)
You did not follow written procedures for holding and distributing operations.
FEI 3002767376
Show all 7 inspections
No action indicated · No objectionable conditions found
Inspected
Davie, Florida
FEI 3002767376
No action indicated · No objectionable conditions found
Inspected
Davie, Florida
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
9 citations posted:
- Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
- Instruments - calibration (21 CFR 111.27(b))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Quality control - reject; specification not met (21 CFR 111.113(b)(2))
See all 9 citations
Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
You did not follow written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.
Instruments - calibration (21 CFR 111.27(b))
You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement before the first use to ensure the accuracy and precision of the instruments or controls.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a component, dietary supplement, package and label when an established specification was not met.
Rejected dietary supplements - identify, hold, control (21 CFR 111.370)
You did not clearly identify, hold and control under a quarantine system for appropriate disposition a dietary supplement that was rejected and unsuitable for use in manufacturing, packaging, or labeling operations.
Obsolete labels, packaging - dispose (21 CFR 111.415(h))
You did not suitably dispose of labels and packaging for dietary supplements that are obsolete or incorrect to ensure that they are not used in any future packaging and label operations.
Written procedures - holding (21 CFR 111.453)
You did not establish and follow written procedures for holding and distributing operations.
Record - product complaint; good manufacturing practice (21 CFR 111.570(b)(2))
You did not make and keep a written record of every product complaint that was related to good manufacturing practice.
Raw materials - Allergen identification (21 CFR 117.80(b)(8))
You did not identify and hold raw materials and other ingredients that are food allergens, and rework that contains food allergens, in a manner that protects against allergen cross-contact.
FEI 3002767376
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Davie, Florida
6 citations posted:
- Instruments - calibration (21 CFR 111.27(b))
- Quality control - reject; specification not met (21 CFR 111.113(b)(2))
- Product received - identify (21 CFR 111.165(d)(1))
- Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))
See all 6 citations
Instruments - calibration (21 CFR 111.27(b))
You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement at the frequency specified in writing by the manufacturer or at routine intervals or as necessary to ensure the accuracy and precision of the instruments or controls.
Quality control - reject; specification not met (21 CFR 111.113(b)(2))
Your quality control personnel did not reject a component when an established specification was not met.
Product received - identify (21 CFR 111.165(d)(1))
You did not identify each unique lot within each unique shipment of received product in a manner that allows you to trace the lot to the status of the received product.
Batch record - quality control review; monitoring (21 CFR 111.260(l)(1)(i))
Your batch production records did not include documentation that quality control personnel reviewed required monitoring operations.
Obsolete labels, packaging - dispose (21 CFR 111.415(h))
You did not suitably dispose of labels and packaging for dietary supplements that are obsolete or incorrect to ensure that they are not used in any future packaging and label operations.
Written procedures - holding (21 CFR 111.453)
You did not follow written procedures for holding and distributing operations.
FEI 3002767376
Official action indicated · Regulatory or administrative action recommended
Inspected
Davie, Florida
3 citations posted:
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Quality control operations - packaged, labeled; specifications (21 CFR 111.127(d))
- Product complaint - quality control investigate (21 CFR 111.560(a)(2))
Full citation text
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.
Quality control operations - packaged, labeled; specifications (21 CFR 111.127(d))
Your quality control operations did not include determining whether the finished dietary supplement conforms to established specifications.
Product complaint - quality control investigate (21 CFR 111.560(a)(2))
A qualified person did not investigate a product complaint that involved a possible failure of a dietary supplement to meet a specification, or other requirement.
FEI 3002767376
Official action indicated · Regulatory or administrative action recommended
Inspected
Davie, Florida
5 citations posted:
- Specifications - product received for packaging, labeling (21 CFR 111.70(f))
- Specifications - finished packaging, labeling (21 CFR 111.70(g))
- Records - quality control operations; responsibilities (21 CFR 111.140(b)(1))
- Master manufacturing record - each batch (21 CFR 111.205(a))
See all 5 citations
Specifications - product received for packaging, labeling (21 CFR 111.70(f))
You did not establish specifications to sufficiently assure that the product you received for packaging or labeling as a dietary supplement is adequately identified and is consistent with your purchase order.
Specifications - finished packaging, labeling (21 CFR 111.70(g))
You did not establish specifications for the packaging and labeling of the finished dietary supplement, to ensure that you used the specified packaging, and to ensure that you applied the specified label.
Records - quality control operations; responsibilities (21 CFR 111.140(b)(1))
You did not make and keep written procedures for the responsibilities of the quality control operations.
Master manufacturing record - each batch (21 CFR 111.205(a))
You did not prepare and follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.
Batch record - every batch (21 CFR 111.255(a))
You did not prepare a batch production record every time you manufactured a batch of dietary supplement.
FEI 3002767376
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What we checked, and what we didn’t
Confirmed from public registry listings
Last checked
- NSF/ANSI 455-2 GMP certification
- USDA Organic certified operation
- 2 facility addresses
- Dosage forms in the certified scope
- Operations listed for each facility
- Product types on its USDA Organic certificate (organic items only)
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
Ask about these in your quote request. How we verify
Other gummy manufacturers in the United States
NSF lists 4 gummy facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 gummy facilities, including one in St. Augustine, FL
St. Augustine, FL, United Statesactivegummy.com
- Gummies
Operations:- Molding
- Coating
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Merrilville, IN
Merrilville, IN, United Statesalbanesecandy.com
- Gummies
Operations:- Molding
- Liquid formulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Miami, FL
Miami, FL, United Statesalfavitamins.com
- Capsules
- Gummies
- Liquids
- Softgels
- Tablets
Operations:- Pasteurization
- Coating
- Liquid formulation
- Tablet compression
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a gummy facility in Dallas, TX
Dallas, TX, United Statesforeverliving.com
- Gummies
- Liquids
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Liquid formulation
- Tablet compression
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026